Published in
IOS Press, Cancer Biomarkers, 4(20), p. 435-441
DOI: 10.3233/cbm-170191
Links
- ORCID
- IOS Press
- [hal-univ-rennes1.archives-ouvertes.fr] | PDF
- [hal-univ-rennes1.archives-ouvertes.fr] | PDF
Tools
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients
Journal article published in 2017 by
Véronique Quillien,
Audrey Lavenu,
François Ducray,
David Meyronet,
Olivier Chinot 
,
Frédéric Fina,
Marc Sanson,
Catherine Carpentier,
Lucie Karayan-Tapon,
Pierre Rivet,
Natacha Entz-Werle,
Michèle Legrain,
Emmanuèle Lechapt Zalcman,
Guenaelle Levallet,
Fabienne Escande
and other authors.
,
Frédéric Fina,
Marc Sanson,
Catherine Carpentier,
Lucie Karayan-Tapon,
Pierre Rivet,
Natacha Entz-Werle,
Michèle Legrain,
Emmanuèle Lechapt Zalcman,
Guenaelle Levallet,
Fabienne Escande
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 